U.S. Companies Issuing Profit Outlooks for Sept. 16

The following U.S. companies provided their financial outlooks today:

================================================================================
                               Sept. 16
                                   2011 Q3/11  Q4/11    2011   2012  Total
================================================================================
                                          ------------Cumulative------------
Total:                                3    416      2  2,348    153   6,268
 Up:                                  0     56      0    529     39     23%
 Down                                 0    164      1    516     17     25%
 Neutral                              1    189      1  1,188     45     46%
 Ex-Item Charges                      2      7      0    115     52      5%
--------------------------------------------------------------------------------
S&P 500:                              0    110      0    695     66   1,779
 Up:                                  0     10      0    142     18     22%
 Down                                 0     45      0    148      6     23%
 Neutral                              0     51      0    360     18     48%
 Ex-Item Charges                      0      4      0     45     24      7%
================================================================================
                                         Up/
      Company                   Period  Down  Guidance
================================================================================
BABY  Natus Medical Inc          2012     X   Expects $0.08 eps addition from
                                              acquisition of Embla Systems.
                                              Mean estimate is $0.73;
                                                 range $0.69 to $0.87.
--------------------------------------------------------------------------------
RLOG  Rand Logistics Inc         2011     N   Expects eps of $0.41 to $0.50.
                                              No estimate available.

--------------------------------------------------------------------------------
VIVO  Meridian Bioscience Inc    2012     X   Expects $0.02 to $0.01 eps charge from
                                              consolidation of Life Science
                                              operations.
                                              Mean estimate is $0.86;
                                                 range $0.77 to $1.00.
--------------------------------------------------------------------------------
================================================================================
NOTE: * Denotes company is in the S&P 500. Cumulative figures
begin in July 2010. Up (U), Down (D) and Neutral (N) ratings are
based on a comparison between the company forecast and the
consensus analyst estimate. Ex-item (X) charges are company
================================================================================
                                         Up/
      Company                   Period  Down  Guidance
================================================================================
announced extraordinary items which will have an impact on
future earnings per share.

SOURCE: Bloomberg

To contact the reporter on this story: Mike Sebany in Washington at msebany@bloomberg.net

To contact the editor responsible for this story: Alex Tanzi at atanzi@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.